📰 "Molecular switching from morule to squamous metaplasia via p40 and the EBP50/S100A4/myosin 9 axis in endometrial carcinoma"
https://doi.org/doi:10.1016/j.ajpath.2026.03.008
https://pubmed.ncbi.nlm.nih.gov/41881309/
#Myosin
📰 "Rapid and repeated evolution of myosin copy number in threespine stickleback"
https://doi.org/doi:10.1016/j.cub.2026.02.052
https://pubmed.ncbi.nlm.nih.gov/41881010/
#Myosin
📰 "Molecular mechanics of smooth muscle contraction and relaxation modulated by caldesmon"
https://www.biorxiv.org/content/10.64898/2026.03.23.713758v1?rss=1
#Myosin
Molecular mechanics of smooth muscle contraction and relaxation modulated by caldesmon

Smooth muscle (SM) contraction is well known to be regulated by the reversible phosphorylation of the myosin regulatory light chain. However, SM force generation and relaxation are often uncoupled from myosin phosphorylation levels (e.g. the latch-state), indicating that additional regulatory mechanisms must be at play. The precise effects of the actin binding protein caldesmon (CaD) on SM force production and relaxation remain ambiguous, largely due to contradictory findings in experiments performed at the tissue level. To date, there are no studies that have measured the effects of CaD on force and relaxation at the molecular level. Here, we use a laser-trap assay to measure the force produced by SM myosin molecules in the presence and absence of CaD. Measurements were performed before and during myosin dephosphorylation, thus simulating SM contraction and relaxation in-vitro. We demonstrate that CaD inhibits force generation, most likely through competitive inhibition of actomyosin binding while simultaneously introducing a resistive load via tethering of actin and myosin. We also establish CaD as a potentiator of relaxation, increasing force decay rate during myosin dephosphorylation. Finally, we show that CaD directly modulates the dependence of myosin-actin mechanics on myosin phosphorylation levels. These findings refine our understanding of SM regulation, highlighting CaD not merely as a passive structural stabilizer, but as a critical regulatory component of force development and relaxation. Ultimately, understanding these mechanical functions offers new perspectives on pathophysiologies involving SM, such as asthma, hypertension, and gastrointestinal disorders, potentially guiding targeted therapeutic strategies. ### Competing Interest Statement The authors have declared no competing interest. Natural Sciences and Engineering Research Council, https://ror.org/01h531d29, RGPIN-2024-06906, PGSD-589894–2024

bioRxiv
📰 "Molecular mechanics of smooth muscle contraction and relaxation modulated by caldesmon"
https://www.biorxiv.org/content/10.64898/2026.03.23.713758v1?rss=1 #Mechanics #Myosin #Force
Molecular mechanics of smooth muscle contraction and relaxation modulated by caldesmon

Smooth muscle (SM) contraction is well known to be regulated by the reversible phosphorylation of the myosin regulatory light chain. However, SM force generation and relaxation are often uncoupled from myosin phosphorylation levels (e.g. the latch-state), indicating that additional regulatory mechanisms must be at play. The precise effects of the actin binding protein caldesmon (CaD) on SM force production and relaxation remain ambiguous, largely due to contradictory findings in experiments performed at the tissue level. To date, there are no studies that have measured the effects of CaD on force and relaxation at the molecular level. Here, we use a laser-trap assay to measure the force produced by SM myosin molecules in the presence and absence of CaD. Measurements were performed before and during myosin dephosphorylation, thus simulating SM contraction and relaxation in-vitro. We demonstrate that CaD inhibits force generation, most likely through competitive inhibition of actomyosin binding while simultaneously introducing a resistive load via tethering of actin and myosin. We also establish CaD as a potentiator of relaxation, increasing force decay rate during myosin dephosphorylation. Finally, we show that CaD directly modulates the dependence of myosin-actin mechanics on myosin phosphorylation levels. These findings refine our understanding of SM regulation, highlighting CaD not merely as a passive structural stabilizer, but as a critical regulatory component of force development and relaxation. Ultimately, understanding these mechanical functions offers new perspectives on pathophysiologies involving SM, such as asthma, hypertension, and gastrointestinal disorders, potentially guiding targeted therapeutic strategies. ### Competing Interest Statement The authors have declared no competing interest. Natural Sciences and Engineering Research Council, https://ror.org/01h531d29, RGPIN-2024-06906, PGSD-589894–2024

bioRxiv
📰 "Interplay between membrane protrusive activities and their adhesion strength regulates cell migration"
https://doi.org/doi:10.1091/mbc.E25-12-0621
https://pubmed.ncbi.nlm.nih.gov/41880217/
#Myosin
📰 "Stall force measurement of the kinesin-3 motor KIF1A using a programmable DNA origami nanospring"
https://doi.org/doi:10.7554/eLife.108477
https://pubmed.ncbi.nlm.nih.gov/41879504/
#Kinesin #Myosin #Forces #Force
Stall force measurement of the kinesin-3 motor KIF1A using a programmable DNA origami nanospring

A DNA origami nanospring introduces a force-sensing technology that enables measurement of motor protein stall forces without optical trapping, detecting force changes in kinesin KIF1A and its disease-related mutants.

eLife
📰 "Stall force measurement of the kinesin-3 motor KIF1A using a programmable DNA origami nanospring"
https://doi.org/doi:10.7554/eLife.108477
https://pubmed.ncbi.nlm.nih.gov/41879504/
#Kinesin #Myosin
Stall force measurement of the kinesin-3 motor KIF1A using a programmable DNA origami nanospring

A DNA origami nanospring introduces a force-sensing technology that enables measurement of motor protein stall forces without optical trapping, detecting force changes in kinesin KIF1A and its disease-related mutants.

eLife
📰 "One- and two-year structural changes of mavacamten therapy in hypertrophic obstructive cardiomyopathy: a case report with serial comprehensive CMR demonstrating continuous reverse remodelling"
https://doi.org/doi:10.1093/ehjcr/ytag165
https://pubmed.ncbi.nlm.nih.gov/41877729/
#Myosin
📰 "Novel drugs targeting genetic variants: current applications and future prospects in heart failure treatment"
https://doi.org/doi:10.3389/fmolb.2026.1781854
https://pubmed.ncbi.nlm.nih.gov/41868102/
#Myosin
Frontiers | Novel drugs targeting genetic variants: current applications and future prospects in heart failure treatment

Chronic heart failure (HF) is a common and frequently occurring disease worldwide, and its traditional treatment methods are undergoing earth-shaking changes...

Frontiers
📰 "Retraction notice to "Inhibition of non-muscular myosin light chain kinase accelerates the clearance of inflammatory cells by promoting the lysosome-mediated cell death" [Biomedicine & Pharmacotherapy 170 (2024) 115986]"
https://doi.org/doi:10.1016/j.biopha.2026.119226
https://pubmed.ncbi.nlm.nih.gov/41862342/
#Myosin